Clinical trial
Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black…
NCT00477334 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00477334 |
|---|---|
| Title | Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients |
| Official title | A Randomized, Multicenter, Double-blind Study to Compare the Efficacy of Single-day Treatment (1000 mg b.i.d.) With Famciclovir Compared to That of Placebo in Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Immunocompetent Black Patients |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Genital Herpes |
| Intervention type | Drug |
| Interventions | Famciclovir, Placebo |
| Enrollment | 463 |
| Start date | Jun 1, 2007 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | May 23, 2007 |
| Last update posted | Mar 28, 2011 |
| Countries | South Africa, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: